FARALLON CAPITAL MANAGEMENT LLC
Q4 2025 13F Holdings
- Locationsan francisco, CA
- Num holdings
151
- Value ($000)
$21,192,105
- Date Filed02/17/2026
- Form type13F-HR
- CIK0000909661
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q4 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
SPDR S&P 500 ETF TR | TR UNIT | 78462F103 | $2.05B | 10 % | 3,000,000 | put | |
REVOLUTION MEDICINES INC | COM | 76155X100 | $1.16B | 6 % | 14,582,796 | ||
MICROSOFT CORP | COM | 594918104 | $1.07B | 5 % | 2,214,079 | ||
AMAZON COM INC | COM | 023135106 | $1.04B | 5 % | 4,499,894 | ||
AON PLC | SHS CL A | G0403H108 | $940.51M | 4 % | 2,665,238 | ||
NATERA INC | COM | 632307104 | $896.74M | 4 % | 3,914,366 | ||
BOSTON SCIENTIFIC CORP | COM | 101137107 | $709.36M | 3 % | 7,439,564 | ||
INVESCO EXCHANGE TRADED FD T | S&P500 EQL WGT | 46137V357 | $689.62M | 3 % | 3,600,000 | put | |
EXELIXIS INC | COM | 30161Q104 | $688.55M | 3 % | 15,709,500 | ||
BRIDGEBIO PHARMA INC | COM | 10806X102 | $688.29M | 3 % | 8,998,463 |
Rows Per Page
10
- 5
- 10
- 20
- 30
- 50
- 100